Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Income towards Parent Company: 2009-2025

Historic Income towards Parent Company for Gyre Therapeutics (GYRE) over the last 16 years, with Sep 2025 value amounting to $5.9 million.

  • Gyre Therapeutics' Income towards Parent Company rose 107.84% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 112.80%. This contributed to the annual value of $16.9 million for FY2024, which is 119.58% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Income towards Parent Company of $5.9 million as of Q3 2025, which was up 276.65% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Income towards Parent Company peaked at $51.6 million during Q2 2022, and registered a low of -$101.8 million during Q4 2023.
  • Moreover, its 3-year median value for Income towards Parent Company was $3.8 million (2023), whereas its average is -$5.3 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first slumped by 453.20% in 2021, then soared by 359.09% in 2022.
  • Over the past 5 years, Gyre Therapeutics' Income towards Parent Company (Quarterly) stood at -$20.3 million in 2021, then slumped by 41.75% to -$28.8 million in 2022, then slumped by 253.66% to -$101.8 million in 2023, then soared by 99.57% to -$433,000 in 2024, then spiked by 107.84% to $5.9 million in 2025.
  • Its Income towards Parent Company was $5.9 million in Q3 2025, compared to $1.6 million in Q2 2025 and $3.7 million in Q1 2025.